Suppression of local immune response by GrB expression in gastric cancer cells

Chinese Medical Journal

Volumn 117, Issue 10, 2004, Pages 1573-1575

  Zhou, Ye Jiang ^a   Xiong, Yu Xia ^a   Li, Chang Ping ^a   Shi, De ^b  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; GrB expression; GrB+CTL; NK cells; S 100+DCS

Indexed keywords

CYTOTOXIC FACTOR; PROTEIN S 100;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CANCER;

DENDRITIC CELLS; GRANZYMES; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; MULTIVARIATE ANALYSIS; S100 PROTEINS; SERINE ENDOPEPTIDASES; STOMACH NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 8844273312     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Yamashita Y, Yatabe Y, Tsuzuki T, et al. Perforin and granzyme expression in cytotoxic T-cell lymphomas. Mod Pathol 1998;11:313-323.
2. Maarien H, Francoise A, Geelen J, et al. Expression of cytotoxic proteins by Neoplastic T cells in Mycosis Fungoieles in creases with progression from plaque stage to tumour stage disease. Am J Path 1999;154:1203-1210.
3. Tory A, Davidson P, Atkinson C, et al. Phenotypic characteristaion of the dendritic cells infiltrated in prostate cancer. J Urol 1998;160:214-219.
4. Troy J, Summers L, Davidson T, et al. Minimal recruitment and activation of dendritic cells infiltrated with in renal cell carcinoma. Clin Cancer Res 1998;4:485-593.
5. Rosen D, Li H, Keidar S, et al. Tumour immunity in perforin-deficient mice: a role for CD95 (FAS/APO-1). J Immunol 2000;164:3229-3235.
6. Hirst CE, Buzza MS, Bird CH, et al. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J Immunol 2003;170:805-815.